Skip to content
Screener

Arrowhead Research ARWR Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$231.56M+41.3%
ALN
Alnylam PharmaceuticalsALNY
$183.36M-4.7%
Assembly Biosciences logo
Assembly BiosciencesASMB
$2.37M-19.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$98.15M-4.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$19.65M-17.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$17.23M+140%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.12B+438%
Enterprise value$12.04B+439%
P/S19.5×+15.6×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Total current assets1,839,751950,639
Property, plant and equipment, net374,822382,515
Intangible assets, net6,0116,861
Right-of-use assets42,79443,891
Other assets4,8871,389
Total Assets$2,268,265$1,385,295
LIABILITIES, NONCONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY
Current liabilities:

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's operating lease ROU assets?
Arrowhead Research (ARWR) reported operating lease ROU assets of $42.79M in Q1 2026.
How has Arrowhead Research's operating lease ROU assets changed year-over-year?
Arrowhead Research's operating lease ROU assets decreased by 3.7% year-over-year, from $44.45M to $42.79M.
What is the long-term trend for Arrowhead Research's operating lease ROU assets?
Over 4 years (2021 to 2025), Arrowhead Research's operating lease ROU assets has grown at a 26.1% compound annual growth rate (CAGR), from $17.35M to $43.89M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Arrowhead Research's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude